Indiana Senate Bill 211 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 4 2012 - 25% progression, died in committee
Action: 2012-01-04 - First reading: referred to Committee on Health and Provider Services
Pending: Senate Health and Provider Services Committee
Text: Latest bill text (Introduced) [HTML]

Requires the drug utilization review board (board) to establish a competitive bidding program for generically equivalent drug product manufacturers (manufacturer) of drugs in therapeutic drug classifications with at least three manufactured generically equivalent drug products. Requires a manufacturer that participates in Medicaid or the children's health insurance program (CHIP) to participate in the competitive bidding program. Requires the board to establish a Medicaid preferred generic drug list (list) based on the successful bids and requires prior authorization on the Medicaid program and CHIP for a generically equivalent drug product that is not included on the list. Requires a manufacturer of a generically equivalent drug product that is included on the list to offer state supplement rebates. Requires the office of Medicaid policy and planning to request bids under the competitive bidding program at least one time every five years.

Generic drug bidding program.

Sen. Beverly Gard [R]

Date	Chamber	Action
2012-01-04		First reading: referred to Committee on Health and Provider Services
2012-01-04		Authored by Senator Gard

Type	Source
Summary	http://www.in.gov/apps/lsa/session/billwatch/billinfo?year=2012&session=1&request=getBill&doctype=SB&docno=0211
Text	http://www.in.gov/legislative/bills/2012/IN/IN0211.1.html